Valiant Evo US Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02652949

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02652949
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02652949. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04 (actual); primary completion 2017-12 (actual). Results posted on 2019-02-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Valiant Evo US Clinical Trial
Acronym
VEVO
Condition
Aortic Aneurysm, Thoracic
Intervention (Device)
Valiant Evo Thoracic Stent Graft System
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct02652949
Content hash
bc1d8a056460e9787d81397703f130b7c735d49cfe969177f1f1b1aa7ac35a18